CompletedNCT01339689
A Proof-of-Concept, Study of Ganaxolone in PTSD
Medication studyAges 18–55United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 55 years.
- Listed locations
- San Diego, United States · Washington D.C., United States and 6 more locationsSee all locations and recruitment
- Activities
- Medication described in the protocol · Placebo comparator
- Compensation
- Payment and expense reimbursement have not been verified.
Study information
Study start dateStarted: April 2011
- Recruitment status
- Completed
- Enrollment listed in the registry
- 112
- Sponsor
- Marinus Pharmaceuticals
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT01339689
- Official title
Show the full official title
A Proof-of-Concept, Double-blind, Randomized, Placebo-controlled Study of Ganaxolone in Posttraumatic Stress Disorder
Recruitment & locations
CompletedSan Diego · Washington D.C. · Boston
5 more locations
- Manchester
- Durham
- Cincinnati
- Charleston
- White River Junction
Questions about this study
Who is behind this study?
The study sponsor is Marinus Pharmaceuticals.
Did this study involve medication?
Yes. The study involved medication, including Ganaxolone and Placebo.
Who was this study for?
Listed age limits: 18 years to 55 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me